| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.36 | 0.08 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.08 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.098 | 0.09 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.09 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |